Cart 0 Product Products (empty)
No products
To be determined Shipping
0,00 € Total
Prices are tax excluded
Product successfully added to your shopping cart
Quantity
Total
There are 0 items in your cart. There is 1 item in your cart.
Total products (tax excl.)
Total shipping (tax excl.) To be determined
Total (tax excl.)
Data sheet of CD58 monoclonal antibody, clone MEM-63 (PE)
| Brand | Abnova |
| Product type | Primary antibodies |
| Reactivity | Human,Pig |
| Host species | Mouse |
| Applications | Flow Cyt |
More info about CD58 monoclonal antibody, clone MEM-63 (PE)
| Brand: | Abnova |
| Reference: | MAB5007 |
| Product name: | CD58 monoclonal antibody, clone MEM-63 (PE) |
| Product description: | Mouse monoclonal antibody raised against native CD58. |
| Clone: | MEM-63 |
| Isotype: | IgG1 |
| Gene id: | 965 |
| Gene name: | CD58 |
| Gene alias: | LFA-3|LFA3 |
| Gene description: | CD58 molecule |
| Immunogen: | Native purified CD58 from NALM-6 human pre-B cell line. |
| Form: | Liquid |
| Recommend dilutions: | Flow Cytometry (20 ul in human blood cells 100 ul in whole blood or 106 cells in a suspension) The optimal working dilution should be determined by the end user. |
| Storage buffer: | In PBS (0.2% BSA, 0.09% sodium azide) |
| Storage instruction: | Store in the dark at 4°C. Do not freeze. Avoid prolonged exposure to light. Aliquot to avoid repeated freezing and thawing. |
| Note: | This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only. |
| Conjugate tag: | PE |
| Product type: | Primary antibodies |
| Host species: | Mouse |
| Antigen species / target species: | Human |
| Specificity: | This antibody reacts with CD58 (LFA-3), a 40-70 KDa glycoprotein distributed over many tissues, leukocytes, erythrocytes, endothelial cells, epithelial cells and fibroblasts. |
| Reactivity: | Human,Pig |
| Applications: | Flow Cyt |
| Shipping condition: | Blue Ice |
| Publications: | Expression of CD58 in normal, regenerating and leukemic bone marrow B cells: implications for the detection of minimal residual disease in acute lymphocytic leukemia.Veltroni M, De Zen L, Sanzari MC, Maglia O, Dworzak MN, Ratei R, Biondi A, Basso G, Gaipa G. Haematologica. 2003 Nov;88(11):1245-52. |